ロード中...
Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas
A novel therapy for Epstein-Barr virus (EBV)-positive tumors involves the intentional induction of the lytic form of EBV infection combined with ganciclovir (GCV) treatment. Virally encoded kinases (thymidine kinase and BGLF4) which are expressed only during the lytic form of infection convert GCV (...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369434/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14747554/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.4.1893-1902.2004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|